Funded Tech Companies
Entrada Therapeutics
Wondering who provided funding to Entrada Therapeutics? Roche Venture Fund, Moore Strategic Ventures and Greenspring Global Partners invested in this biopharmaceutical company.
Company Overview
Company Name
Entrada Therapeutics
Company Status
Publicly-held
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
6 Tide St.
Boston, MA 02210
USA
Boston, MA 02210
USA
Phone
Undisclosed
Website
Email Address
Company Background Information
Overview
Entrada Therapeutics' mission is to treat devastating diseases through the intracellular delivery of biologics. Entrada's technology enables the efficient intracellular delivery of proteins, peptides and nucleic acids, thus allowing for the development of programs across several intracellular target classes.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
10/29/2021
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
Dipal Doshi
Chief Financial Officer
Kory Wentworth
Chief Medical Officer
Nerissa Kreher
Chief Operating Officer
Nathan Dowden
Chief Scientific Officer
Natarajan Sethuraman
VP - General Counsel
Jared Cohen
VP - Human Resources
Kerry Robert
Company Investors
- Roche Venture Fund
- Moore Strategic Ventures
- Greenspring Global Partners
- Wellington Management Company
- Agent Capital
- Point72 Ventures
- TCG Crossover
- MRL Ventures
- 5AM Ventures (Kush Parmar)
- MPM Capital (Todd Foley)
- Goldman Sachs
- Redmile Group
- CureDuchenne Ventures
- Qatar Investment Authority
Browse more funded tech companies:
Share this article
About Our VC Deals Database
This tech company profile is powered by VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs